ARCH Venture Partners VIII, LLC's Net Worth

$720 Million

Who is ARCH Venture Partners VIII, LLC?

ARCH Venture Partners VIII, LLC has an estimated net worth of $720 Million. This is based on reported shares across multiple companies, which include Neumora Therapeutics, Inc., Scholar Rock Holding Corp, Quanterix Corp, Denali Therapeutics Inc., Twist Bioscience Corp, Metacrine, Inc., Unity Biotechnology, Inc., Codiak BioSciences, Inc., Sienna Biopharmaceuticals, Inc., and Homology Medicines, Inc..

SEC CIK

ARCH Venture Partners VIII, LLC's CIK is 0001616165

Past Insider Trading and Trends

2018 was ARCH Venture Partners VIII, LLC's most active year for acquiring shares with 18 total transactions. ARCH Venture Partners VIII, LLC's most active month to acquire stocks was the month of August. 2018 was ARCH Venture Partners VIII, LLC's most active year for disposing of shares, totalling 17 transactions. ARCH Venture Partners VIII, LLC's most active month to dispose stocks was the month of April. 2023 saw ARCH Venture Partners VIII, LLC paying a total of $25,500,000.00 for 18,924,704 shares, this is the most they've acquired in one year. In 2020 ARCH Venture Partners VIII, LLC cashed out on 30,643,367 shares for a total of $0.00, their largest year based on trade value.